National Policy on Traditional Medicine and Regulation of Herbal Medicines - Report of a WHO Global Survey
(2005; 168 pages) View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentExecutive summary
View the documentAcronyms, abbreviations and definitions
View the documentWHO Regions
Open this folder and view contents1. Introduction
Open this folder and view contents2. National policy on traditional medicine and complementary/alternative medicine
Close this folder3. The regulatory situation of herbal medicines
View the document3.1 Law or regulation on herbal medicines
View the document3.2 Regulatory status of herbal medicines
View the document3.3 Claims
View the document3.4 Pharmacopoeias
View the document3.5 Monographs on herbal medicines
View the document3.6 Manufacture of herbal medicines
View the document3.7 Safety and herbal medicines
View the document3.8 Registration system for herbal medicines
View the document3.9 Herbal medicines and the essential drug list
View the document3.10 Post marketing surveillance of herbal medicines
View the document3.11 The sale of herbal medicines
View the document3.12 Annual market sales of herbal medicines
Open this folder and view contents4. Member States, WHO and herbal medicines
Open this folder and view contents5. Country summaries
View the documentReferences
View the documentAnnex 1. Text of survey instrument
 

3.12 Annual market sales of herbal medicines

In the final question in this section related to the regulation of herbal medicines, countries were asked to provide data about annual market sales for herbal medicine for the most recent three years. The question also asked for clarification of the source of the figures provided.

Thirty countries provided some data on annual market sales of herbal medicines. However, as the data were largely fragmentary, the compiled results represent the nine Member States that included data for the period 1999-2001. It includes Member States from all six WHO Regions, with varying levels of economic development. The data which were excluded from the compilation were not complete, or were not provided for the chosen period. Finally, some countries provided figures in terms of packs of tablets or bottles of tonics, but such figures are not comparable between countries.

The nine States included in the results below (Figure 42) are Bhutan, Canada, Czech Republic, Islamic Republic of Iran, Madagascar, Malaysia, Pakistan, Sudan and Sweden. When figures were given in local currency, they were converted to United States dollars, using the exchange rates published by the United Nations on 1 November 2003.

The data excluded from the compilation above provide further evidence of the rise in annual market sales of herbal medicine globally.


Figure 42. Annual market sales of herbal medicines in nine countries, 1999-2001

 

to previous section to next section
 

Last updated: May 3, 2013